An Australian-led world first clinical trial using medical 'superglue' to improve life for emphysema patients is showing promising results, offering hope to those with no other treatment options.
Breakdown
- Emphysema restricts lung function and often leaves patients with limited mobility.
- Traditional valve treatments are not suitable for about 40% of patients due to holes between lung lobes. 31s
- A team at the Royal Adelaide Hospital is trialing a glue injection to block these holes. 40s
- Patient Dodie Briggs received the glue treatment and later benefited from valve therapy, improving her quality of life. 1m 5s
- The trial is available in Adelaide, Brisbane, and Sydney for patients with no other treatment options. 1m 21s